X, H., B, Y., Q, H., Q, Z., B, C., J, W., . . . K, S. (2025). Repurposing Antidiabetic Drugs for Cerebrovascular Diseases: Causal Evidence from Drug Target Mendelian Randomization and Colocalization. Molecular neurobiology, 62(9), 11596. https://doi.org/10.1007/s12035-025-04987-2
Chicago Style (17th ed.) CitationX, Huang, Yin B, Hu Q, Zheng Q, Chen B, Wang J, Ji X, and Su K. "Repurposing Antidiabetic Drugs for Cerebrovascular Diseases: Causal Evidence from Drug Target Mendelian Randomization and Colocalization." Molecular Neurobiology 62, no. 9 (2025): 11596. https://doi.org/10.1007/s12035-025-04987-2.
MLA (9th ed.) CitationX, Huang, et al. "Repurposing Antidiabetic Drugs for Cerebrovascular Diseases: Causal Evidence from Drug Target Mendelian Randomization and Colocalization." Molecular Neurobiology, vol. 62, no. 9, 2025, p. 11596, https://doi.org/10.1007/s12035-025-04987-2.